|
|
The biggest problem with AF management today is the lack of treatment options that are both highly effective and safe. Atrial fibrillation is a disorder found in about 2.2 million Americans. Atrial Fibrillation causes more than 70,000 strokes each year in the U.S., where 160,000 new cases of Atrial Fibrillation are diagnosed each year.
CardioNova Ltd, offers a cutting edge technology that will allow the use of the gold standard procedure Cox-maze (used for Atrial fibrillation treatment) via a percutaneous procedure.
|
|
« Back
|
|
|
|
| Contact: Uri Stein (CEO) |
| Stage: Early Stage |
|
|
|
|
|
